Skip to content
Search

Latest Stories

New guidance for entry to independent prescribing courses to be applicable from 1st October

The General Pharmaceutical Council (GPhC) has announced that the new requirement for independent prescribing courses will be applicable from 1st of October 2022.

Pharmacists currently taking independent prescribing courses and those who apply before 1 October won’t be affected by the changes.


The new guidance was agreed at the council meeting on 8 September and went to the initial education and training Advisory Group on 22 September where it was well received, the GPhC said.

“The guidance is now being finalized to reflect the discussions at the Council meeting and the initial education and training advisory group and will be published in October.”

The new guidance is relevant for both course providers and applicants and gives some specific suggestions and examples of what we may expect. It will support consistency in the way education providers applied the new standards and will help individual pharmacists to understand the relevant experience they would need before enrolling on a course.

“From 1 October 2022 the accreditation and reaccreditation of independent prescribing courses will be to the revised standards. Any course provider wishing to apply the revised entry requirements before they are due for reaccreditation will be invited to go through a short desktop approval process. They will need to submit evidence to show they’ve made the necessary changes to meet the new standards, which will be rapidly reviewed by the GPhC, to ensure a quick turnaround.”

This will allow course providers to accept pharmacists in line with the new entry requirements for their next cohort and potentially allow the change to be implemented as early as autumn 2022.

The council said: “Course providers will need to continue to apply the previous entry requirements until they have been approved against the revised aspects the standards. We recommend therefore that pharmacists wanting to apply for independent prescribing courses should check in advance with their preferred course providers to find out when they expect to be ready to accept applicants using the new entry requirements in the new revised standards.”

Changes to the requirements for entry to accredited independent prescribing courses were agreed by the General Pharmaceutical Council in May 2022. According to new guidance pharmacists will no longer need to have two years of practice and relevant experience in a specific clinical or therapeutic area to enrol in an independent prescribing course.

Instead, applicants must now have relevant experience in a pharmacy setting and be able to recognise, understand and articulate the skills and attributes required by a prescriber. This experience and awareness will act as the basis of their prescribing practice whilst training. Applicants must also identify an area of clinical or therapeutic practice on which to base their learning.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less